DOCSLIB.ORG

The Commonwealth of Massachusetts Executive Office of Health and Human Services Office of Medicaid One Ashburton Place, Room 1109 Boston, Massachusetts 02108

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Commonwealth of Massachusetts Executive Office of Health and Human Services Office of Medicaid One Ashburton Place, Room 1109 Boston, Massachusetts 02108 The Commonwealth of Massachusetts Executive Office of Health and Human Services Office of Medicaid One Ashburton Place, Room 1109 Boston, Massachusetts 02108 Administrative Bulletin 15-02 CHARLES D. BAKER DANIEL TSAI Governor Assistant Secretary for 114.3 CMR 16.00: Surgery and MassHealth KARYN E. POLITO Anesthesia Services Lieutenant Governor 101 CMR 317.00: Medicine Tel: (617) 573-1600 MARYLOU SUDDERS 114.3 CMR 18.00: Radiology Fax: (617) 573-1891 Secretary www.mass.gov/eohhs Effective January 1, 2015 CPT/HCPCS 2015 Coding Updates In accordance with 114.3 CMR 16.01(4), 114.3 CMR 18.01(4), and 101 CMR 317.01(4), the following coding changes are effective on January 1, 2015. The following lists specify those codes that have been added and codes that have been deleted, with crosswalks to new codes that replace corresponding deleted codes. Rates for new codes with relative value units (RVUs) are calculated using the current MassHealth conversion factor. Rates for new codes with one-to-one crosswalks to deleted codes are set at the current payment rate of the deleted codes. Rates for new codes with one- to-one crosswalks to existing codes are set at the current payment rate for the existing codes. For codes with multiple crosswalks, rates for the 2015 additions are calculated according to the rate methodology used in setting physician rates. All other codes in this bulletin that require pricing are reimbursed by individual consideration (I.C.). Rates listed in this administrative bulletin are applicable until revised rates are issued by the Executive Office of Health and Human Services. Deleted codes are not available for use for dates of service after 2014. 114.3 CMR 16.00 Added Codes Code Description Arthrocentesis, aspiration and/or injection, small joint or bursa (eg, fingers, toes); 20604 with ultrasound guidance, with permanent recording and reporting Arthrocentesis, aspiration and/or injection, intermediate joint or bursa (eg, 20606 temporomandibular, acromioclavicular, wrist, elbow or ankle, olecranon bursa); with ultrasound guidance, with permanent recording and reporting Arthrocentesis, aspiration and/or injection, major joint or bursa (eg, shoulder, hip, 20611 knee, subacromial bursa); with ultrasound guidance, with permanent recording and reporting Ablation therapy for reduction or eradication of 1 or more bone tumors (eg, 20983 metastasis) including adjacent soft tissue when involved by tumor extension, percutaneous, including imaging guidance when performed; cryoablation Open treatment of rib fracture(s) with internal fixation, includes thoracoscopic 21811 visualization when performed, unilateral; 1-3 ribs Open treatment of rib fracture(s) with internal fixation, includes thoracoscopic 21812 visualization when performed, unilateral; 4-6 ribs Open treatment of rib fracture(s) with internal fixation, includes thoracoscopic 21813 visualization when performed, unilateral; 7 or more ribs Percutaneous vertebroplasty (bone biopsy included when performed), 1 vertebral 22510 body, unilateral or bilateral injection, inclusive of all imaging guidance; cervicothoracic Percutaneous vertebroplasty (bone biopsy included when performed), 1 vertebral 22511 body, unilateral or bilateral injection, inclusive of all imaging guidance; lumbosacral Percutaneous vertebroplasty (bone biopsy included when performed), 1 vertebral body, unilateral or bilateral injection, inclusive of all imaging guidance; each additional 22512 cervicothoracic or lumbosacral vertebral body (list separately in addition to code for primary procedure) Percutaneous vertebral augmentation, including cavity creation (fracture reduction and bone biopsy included when performed) using mechanical device (eg, 22513 kyphoplasty), 1 vertebral body, unilateral or bilateral cannulation, inclusive of all imaging guidance; thoracic Percutaneous vertebral augmentation, including cavity creation (fracture reduction 22514 and bone biopsy included when performed) using mechanical device 1 vertebral body, unilateral or bilateral cannulation, inclusive of all imaging guidance; lumbar Percutaneous vertebral augmentation, including cavity creation (fracture reduction and bone biopsy included when performed) using mechanical device 1 vertebral 22515 body, unilateral or bilateral cannulation, inclusive of all imaging guidance; each additional thoracic or lumbar vertebral body (list separately in addition to code for primary procedure) Total disc arthoplasty (artificial disc), anterior approach including discectomy with end plate preparation (includes osteophytectomy for nerve root or spinal cord 22858 decompression and microdissection); second level, cervical (list separately in addition to code for primary procedure) Arthrodesis, sacroiliac joint, percutaneous or minimally invasive (indirect 27279 visualization), with image guidance, includes obtaining bone graft when performed, and placement of transfixing device Insertion or replacement of permanent subcutaneous implantable defibrillator system, with subcutaneous electrode, including defibrillation threshold evaluation, induction of 33270 arrhythmia, evaluation of sensing for arrhythmia termination, and programming or reprogramming of sensing or therapeutic parameters, when performed 33271 Insertion of subcutaneous implantable defibrillator electrode 33272 Removal of subcutaneous implantable defibrillator electrode Repositioning of previously implanted subcutaneous implantable defibrillator 33273 electrode Transcatheter mitral valve repair, percutaneous approach, including transseptal 33418 puncture when performed; initial prosthesis Transcatheter mitral valve repair, percutaneous approach, including transseptal 33419 puncture when performed; additional prosthesis(es) during same session (list separately in addition to code for primary procedure) Extracorporeal membrane oxygenation (ECMO)/ extracorporeal life support (ECLS) 33946 provided by physician; initiation, veno-venous 33947 initiation, veno-arterial 33948 daily management, each day, veno-venous 33949 daily management, each day, veno-arterial Insertion of peripheral (arterial and/or venous) cannula, percutaneous, birth through 5 33951 years of age (includes fluoroscopic guidance, when performed) 2 Insertion of peripheral (arterial and/or venous) cannula, percutaneous, 6 years and 33952 older (includes fluoroscopic guidance, when performed) 33953 Insertion of peripheral (arterial and/or venous) cannula, open, birth 5 years of age 33954 Insertion of peripheral (arterial and/or venous) cannula, open, 6 years and older Insertion of central cannula by sternotomy or thoracotomy, birth through 5 years of 33955 age 33956 Insertion of central cannula by sternotomy or thoracotomy, 6 years and older Reposition peripheral (arterial and/or venous) cannula, percutaneous, birth through 5 33957 years of age (includes fluoroscopic guidance, when performed) reposition peripheral (arterial and/or venous) cannula, percutaneous, 6 years and 33958 older (includes fluoroscopic guidance, when performed) Extracorporeal membrane oxygenation (ECMO)/ extracorporeal life support (ECLS) 33959 provided by physician; reposition peripheral (arterial and/or venous) cannula(e), open, birth through 5 years of age, (includes fluoroscopic guidance, when performed) Reposition peripheral (arterial and/or venous) cannula, open, 6 years and older 33962 (includes fluoroscopic guidance, when performed) Reposition of central cannula by sternotomy or thoracotomy, birth through 5 years of 33963 age (includes fluoroscopic guidance, when performed) Reposition of central cannula by sternotomy or thoracotomy,6 years and older 33964 (includes fluoroscopic guidance, when performed) Removal of peripheral (arterial and/or venous) cannula, percutaneous, birth through 5 33965 years of age Removal of peripheral (arterial and/or venous) cannula, percutaneous, 6 years and 33966 older Removal of peripheral (arterial and/or venous) cannula, open, birth through 5 years of 33969 age 33984 Removal of peripheral (arterial and/or venous) cannula, open, 6 years and older Removal of central cannula by sternotomy or thoracotomy, birth through 5 years of 33985 age 33986 Removal of central cannula by sternotomy or thoracotomy, 6 years and older Arterial exposure with creation of graft conduit to facilitate arterial perfusion for 33987 ECMO/ECLS (list separately in addition to code for primary procedure) 33988 Insertion of left heart vent by thoracic incision for ECMO/ECLS 33989 Removal of left heart vent by thoracic incision for ECMO/ECLS Physician planning of patient-specific fenestrated visceral aortic endograft requiring a 34839 minimum of 90 minutes of physician time Transcatheter placement of intravascular stent(s), intrathoracic common carotid 37218 artery or innominate artery, open or percutaneous antegrade approach, including angioplasty, when performed, and radiological supervision and interpretation Esophagoscopy, rigid, transoral with diverticulectomy of hypopharynx or cervical 43180 esophagus, with cricopharyngeal myotomy, includes use of telescope or operating microscope and repair, when performed. Ileoscopy through stoma, diagnostic, including collection of specimen(s) by brushing 44381 or washing, when performed, with transendoscopic balloon dilation Ileoscopy through stoma, diagnostic, including collection of specimen(s) by brushing 44384 or washing, with placement of endoscopic stent (includes pre and post-dilation and guide wire passage, when performed) 3 Colonoscopy through stoma, diagnostic, including collection of specimen(s)
Load more

Recommended publications
  • Focal Spot, Spring 2006
    Washington University School of Medicine Digital Commons@Becker Focal Spot Archives Focal Spot Spring 2006 Focal Spot, Spring 2006 Follow this and additional works at: http://digitalcommons.wustl.edu/focal_spot_archives Recommended Citation Focal Spot, Spring 2006, April 2006. Bernard Becker Medical Library Archives. Washington University School of Medicine. This Book is brought to you for free and open access by the Focal Spot at Digital Commons@Becker. It has been accepted for inclusion in Focal Spot Archives by an authorized administrator of Digital Commons@Becker. For more information, please contact [email protected]. SPRING 2006 VOLUME 37, NUMBER 1 *eiN* i*^ MALLINCKRC RADIOLO AJIVERSITY *\ irtual Colonoscopy: a Lifesaving Technology ^.IIMi.|j|IUII'jd-H..l.i.|i|.llJ.lii|.|.M.; 3 2201 20C n « ■ m "■ ■ r. -1 -1 NTENTS FOCAL SPOT SPRING 2006 VOLUME 37, NUMBER 1 MIR: 75 YEARS OF RADIOLOGY EXPERIENCE In the early 1900s, radiology was considered by most medical practitioners as nothing more than photography. In this 75th year of Mallinckrodt Institute's existence, the first of a three-part series of articles will chronicle the rapid advancement of radiol- ogy at Washington University and the emergence of MIR as a world leader in the field of radiology. THE METABOLISM OF THE DIABETIC HEART More diabetic patients die from cardiovascular disease than from any other cause. Researchers in the Institute's Cardiovascular Imaging Laboratory are finding that the heart's metabolism may be one of the primary mechanisms by which diseases such as diabetes have a detrimental effect on heart function. VIRTUAL C0L0N0SC0PY: A LIFESAVING TECHNOLOGY More than 55,000 Americans die each year from cancers of the colon and rectum.
    [Show full text]
  • Awake Craniotomy for Left Insular Low-Grade Glioma Removal on a Patient with Learning Disabilities
    THIEME Techniques in Neurosurgery 41 Awake Craniotomy for Left Insular Low-Grade Glioma Removal on a Patient with Learning Disabilities Andrej Vranic1 Blaz Koritnik2 Jasmina Markovic-Bozic3 1 Department of Neurosurgery, Fondation Ophtalmologique A. de Address for correspondence Andrej Vranic, MD, PhD, Department of Rothschild, Paris, France Neurosurgery, Fondation Ophtalmologique Adolphe de Rothschild, 2 Department of Neurophysiology, University Medical Centre, 29, Rue Manin, 75019 Paris, France (e-mail: [email protected]). Ljubljana, Slovenia 3 Department of Anesthesiology, University Medical Centre, Ljubljana, Slovenia Indian J Neurosurg 2017;6:41–43. Abstract Introduction Low-grade gliomas (LGG) are slow-growing primary brain tumors in adults, with high tropism for eloquent areas. Standard approach in treatment of LGG is awake craniotomy with intraoperative cortical mapping — a method which is usually used on adult and fully cooperative patients. Case Report We present the case of a patient with learning disabilities (PLD) who Keywords was operated for left insular LGG awake craniotomy, and intraoperative cortical ► low-grade glioma mapping were performed and the tumor was gross totally removed. ► awake craniotomy Conclusion Awake surgery for left insular LGG removal is challenging; however, it ► learning disability can be performed safely and successfully on PLD. Introduction been shown that awake brain tumor surgery can be safely performed with extremely low complication and failure rates Low-grade gliomas (LGG) are slow-growing primary brain regardless of American Society of Anesthesiologists tumors in adults. For many decades, these tumors were classification, body mass index, smoking status, psychiatric or considered inoperable because of their high tropism for emotional history, seizure frequency and duration, tumor site, eloquent areas and white matter pathways.
    [Show full text]
  • Imaging in Double Gall Bladder with Acute Cholecystitis—A Rare Entity
    Surgical Science, 2014, 5, 273-279 Published Online July 2014 in SciRes. http://www.scirp.org/journal/ss http://dx.doi.org/10.4236/ss.2014.57047 Imaging in Double Gall Bladder with Acute Cholecystitis—A Rare Entity Praveen Kumar Vasanthraj, Rajoo Ramachandran, Kumaresh Athiyappan, Anupama Chandrasekharan, Cunnigaiper Dhanasekaran Narayanan Department of Radiology, Sri Ramachandra University, Chennai, India Email: [email protected] Received 28 April 2014; revised 26 May 2014; accepted 22 June 2014 Copyright © 2014 by authors and Scientific Research Publishing Inc. This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/ Abstract Duplication of gall bladder is a rare congenital anomaly of the hepatobiliary system. It is a very important entity in clinical practice as preoperative diagnosis plays a significant role in the man- agement and to avoid unnecessary bile duct injury during surgery. We report a case of duplicated gall bladder presenting as acute cholecystitis. Keywords Gall Bladder, Duplication, Cholecystitis 1. Introduction Gall bladder (GB) duplication is a rare congenital anomaly of hepatobiliary system with a reported incidence of about 1 per 4000 autopsies [1]. Duplication of gall bladder and their varying anatomical positions are associated with an increased risk of complications including biliary leak after laparoscopic or open cholecystectomy [2]-[5]. 2. Case Presentation A 45 years old lady presented with complaints of abdomen pain for the past two days. It was colicky type pain, intermittent in nature and localized to the right hypochondrium. She also gave history of three episodes of vo- miting which was non bilious, non blood stained and non foul smelling.
    [Show full text]
  • F • High Accuracy Sonographic Recognition of Gallstones
    517 - • High Accuracy Sonographic f Recognition of Gallstones Paul C. Messier1 Recent advances in the imaging capabilities of gray scale sonography have increased Donald S. Hill1 the accuracy with which gallstones may be diagnosed. Since the sonographic diagnosis Frank M. Detorie2 of gallstones is often followed by surgery without further confirmatory studies, the Albert F. Rocco1 avoidance of false-positive diagnoses assumes major importance. In an attempt to improve diagnostic accuracy, 420 gallbladder sonograms were evaluated for gall- stones. Positive diagnoses were limited to cases in which the gallbladder was well visualized and contained densities that produced acoustic shadowing or moved rapidly with changes in position. Gallstones were diagnosed in 123 cases and surgery or autopsy in 70 of these patients confirmed stones in 69. There was one false-positive, an accuracy rate for positive diagnosis of 98.6%. Five cases were called indeterminate for stones; one of these had tiny 1 mm stones at surgery. The other four cases had no surgery. Of 276 cases called negative for stones, two were operated. One contained tiny 1 mm stones; the other had no stones. None of the 146 cases with negative sonograms and oral cholecystography or intravenous cholangiography had stones diagnosed by these methods. Because of its ease and simplicity, sonography is attractive as the initial study in patients suspected of having gallstones. With the criteria used here, a diagnosis of gallstones in the gallbladder can be offered with great confidence. Since 1974, the imaging capabilities of gray scale sonography have improved steadily, with corresponding increases in its accuracy in gallstone recognition.
    [Show full text]
  • Cholecystokinin Cholescintigraphy: Methodology and Normal Values Using a Lactose-Free Fatty-Meal Food Supplement
    Cholecystokinin Cholescintigraphy: Methodology and Normal Values Using a Lactose-Free Fatty-Meal Food Supplement Harvey A. Ziessman, MD; Douglas A. Jones, MD; Larry R. Muenz, PhD; and Anup K. Agarval, MS Department of Radiology, Georgetown University Hospital, Washington, DC Fatty meals have been used by investigators and clini- The purpose of this investigation was to evaluate the use of a cians over the years to evaluate gallbladder contraction in commercially available lactose-free fatty-meal food supple- conjunction with oral cholecystography, ultrasonography, ment, as an alternative to sincalide cholescintigraphy, to de- and cholescintigraphy. Proponents assert that fatty meals velop a standard methodology, and to determine normal gall- are physiologic and low in cost. Numerous different fatty bladder ejection fractions (GBEFs) for this supplement. meals have been used. Many are institution specific. Meth- Methods: Twenty healthy volunteers all had negative medical histories for hepatobiliary and gallbladder disease, had no per- odologies have differed, and few investigations have stud- sonal or family history of hepatobiliary disease, and were not ied a sufficient number of subjects to establish valid normal taking any medication known to affect gallbladder emptying. All GBEFs for the specific meal. Whole milk and half-and-half were prescreened with a complete blood cell count, compre- have the advantage of being simple to prepare and admin- hensive metabolic profile, gallbladder and liver ultrasonography, ister (4–7). Milk has been particularly well investigated. and conventional cholescintigraphy. Three of the 20 subjects Large numbers of healthy subjects have been studied, a were eliminated from the final analysis because of an abnormal- clear methodology described, and normal values determined ity in one of the above studies.
    [Show full text]
  • Answer Key Chapter 1
    Instructor's Guide AC210610: Basic CPT/HCPCS Exercises Page 1 of 101 Answer Key Chapter 1 Introduction to Clinical Coding 1.1: Self-Assessment Exercise 1. The patient is seen as an outpatient for a bilateral mammogram. CPT Code: 77055-50 Note that the description for code 77055 is for a unilateral (one side) mammogram. 77056 is the correct code for a bilateral mammogram. Use of modifier -50 for bilateral is not appropriate when CPT code descriptions differentiate between unilateral and bilateral. 2. Physician performs a closed manipulation of a medial malleolus fracture—left ankle. CPT Code: 27766-LT The code represents an open treatment of the fracture, but the physician performed a closed manipulation. Correct code: 27762-LT 3. Surgeon performs a cystourethroscopy with dilation of a urethral stricture. CPT Code: 52341 The documentation states that it was a urethral stricture, but the CPT code identifies treatment of ureteral stricture. Correct code: 52281 4. The operative report states that the physician performed Strabismus surgery, requiring resection of the medial rectus muscle. CPT Code: 67314 The CPT code selection is for resection of one vertical muscle, but the medial rectus muscle is horizontal. Correct code: 67311 5. The chiropractor documents that he performed osteopathic manipulation on the neck and back (lumbar/thoracic). CPT Code: 98925 Note in the paragraph before code 98925, the body regions are identified. The neck would be the cervical region; the thoracic and lumbar regions are identified separately. Therefore, three body regions are identified. Correct code: 98926 Instructor's Guide AC210610: Basic CPT/HCPCS Exercises Page 2 of 101 6.
    [Show full text]
  • Unilateral Prefrontal Lobotomy for Epilepsy: Technique and Surgical Anatomy
    NEUROSURGICAL FOCUS Neurosurg Focus 48 (4):E10, 2020 Unilateral prefrontal lobotomy for epilepsy: technique and surgical anatomy Giulia Cossu, MD,1 Pablo González-López, MD, PhD,2 Etienne Pralong, MD,1 Judith Kalser, MD,3 Mahmoud Messerer, MD, MSc,1 and Roy Thomas Daniel, MD, MCh1 1Department of Neurosurgery, University Hospital of Lausanne; 3Department of Pediatrics, Section of Neuro-Pediatrics, University Hospital of Lausanne, Switzerland; and 2Department of Neurosurgery, Hospital General Universitario de Alicante, Spain OBJECTIVE Surgery for frontal lobe epilepsy remains a challenge because of the variable seizure outcomes after surgery. Disconnective procedures are increasingly applied to isolate the epileptogenic focus and avoid complications related to extensive brain resection. Previously, the authors described the anterior quadrant disconnection procedure to treat large frontal lobe lesions extending up to but not involving the primary motor cortex. In this article, they describe a surgical technique for unilateral disconnection of the prefrontal cortex, while providing an accurate description of the surgical and functional anatomy of this disconnective procedure. METHODS The authors report the surgical treatment of a 5-month-old boy who presented with refractory epilepsy due to extensive cortical dysplasia of the left prefrontal lobe. In addition, with the aim of both describing the subcorti- cal intrinsic anatomy and illustrating the different connections between the prefrontal lobe and the rest of the brain, the authors dissected six human cadaveric brain hemispheres. These dissections were performed from lateral to medial and from medial to lateral to reveal the various tracts sectioned during the three different steps in the surgery, namely the intrafrontal disconnection, anterior callosotomy, and frontobasal disconnection.
    [Show full text]
  • En Bloc Resection of Solitary Cranial Tumors: an Algorithmic Reconstructive Approach
    Published online: 2019-02-28 THIEME e14 Original Article En bloc Resection of Solitary Cranial Tumors: An Algorithmic Reconstructive Approach Sabine A. Egeler, MD1 Anna Rose Johnson, MPH1 Winona Wu, BA1 Alexandra Bucknor, MBBS, MSc1 Yen-Chou Chen, MD2 Ahmed B. Bayoumi, MD3 Ekkehard M. Kasper, MD, PhD2 1 Division of Plastic Surgery, Beth Israel Deaconess Medical Center, Address for correspondence Ekkehard M. Kasper, MD, PhD, FAANS, Harvard Medical School, Boston, Massachusetts Division of Neurosurgery, Hamilton General Hospital, 237 Barton 2 Division of Neurosurgery, Hamilton General Hospital, Michael G. Street East Hamilton, ON L8L 2X2, Canada DeGroote School of Medicine, McMaster University, Hamilton, Ontario (e-mail: [email protected]). 3 Department of Neurosurgery, Bahcesehir University, Bahcesehir, Turkey J Reconstr Microsurg Open 2019;4:e14–e23. Abstract Background This study analyzes the surgical outcomes for single setting surgeries involving en-bloc solitary calvarial tumor resection in combination with three-layered reconstruction, presenting a novel planning algorithm. Methods Data were retrieved for all patients undergoing single-stage tumor excision, using our novel three-layered reconstructive approach (duraplasty, cranioplasty, and soft tissue reconstruction) between 2005 and 2017 at a single tertiary hospital center. Patients 18 years with a Karnofsky Performance score (KPS) >70 and a life expectancy of > 2 months were included. Patient characteristics, surgical specifics, histological diagnoses, outcomes, and complications were reviewed. Results Eighteen single-staged excisions and three-layered reconstructions were per- formed. Seven patients presented with primary tumors and 11 patients with metastases. Mean age was 62 years. Mean follow-uptime was 39 months. Primary closure was used in 12 of 18 patients, microvascular free flap with skin grafting in 4 of 18, and local advancement or rotational flap in 2 of 18.
    [Show full text]
  • Chapter One General Introduction
    Chapter One General Introduction 1.1Introduction: Magnetic resonance cholangiopancreatography (MRCP) is an abdominal magnetic resonance imaging method that allows non-invasive visualization of the pancreatobiliary tree and requires no administration of contrast agent. (Adamek HE et al, 1998). MRCP is increasingly being used as a non-invasive alternative to ERCP and a high percentage of the diagnostic results of MRCP are comparable with those from ERCP for various hepatobiliary pathologies. (Vogl TJ et al.2006). It has been exactly two decades since magnetic resonancecholangiopancreatography (MRCP) was first described. Over this time, the technique has evolved considerably, aided by improvements in spatial resolution and speed of acquisition. It has now an established role in the investigation of many biliary disorders, serving as a non-invasive alternative to endoscopic retrograde cholangiopancreatography (ERCP).It makes use of heavily T2-weighted pulse sequences, thus exploiting the inherent differences in the T2-weighted contrast between stationary fluid-filled structures in the abdomen (which have a long T2 relaxation time) and adjacent soft tissue (which has a much shorter T2 relaxation time). Static or slow moving fluids within the biliary tree and pancreatic duct appear of high signal intensity on MRCP, whilst surrounding tissue is of reduced signal intensity. (WallnerBK ,et al 1991). 1 Heavily T2-weighted images were originally achieved using a gradient-echo (GRE) balanced steady-state free precession technique. A fast spin-echo (FSE) pulse sequence with a long echo time (TE) was then introduced shortly after, with the advantages of a higher signal-to-noise ratio and contrast-to-noise ratio, and a lower sensitivity to motion and susceptibility artefacts.
    [Show full text]
  • Ultrasonography in Hepatobiliary Diseases
    Ultrasonography in Hepatobiliary diseases Pages with reference to book, From 189 To 194 Kunio Okuda ( Department of Medicine, Chiba University School of Medicine, Chiba, Japan (280). ) Introduction of real-time linear scan ultrasonography to clinical practice has revolutionalized the diagnostic approach to hepatobiiary disorders. 1 This modality allows the operator to scan the liver and biliary tract with a real-time effect, and obtain three dimensional images. One can follow vessels and ducts from one end to the other. The portal and hepatic venous systems are readily seen and distinguished. Real-time ultrasonography (US) using an electronically activated linear array transducer is becoming a stethoscope for the liver specialist, because a portable size real-time ültrasonograph is already available. It is now established that real-time US is useful not only in the diagnosis of gallstones, dilatation of the biliary tract, and cystic lesions, but it can also assess liver parenchyma in various diffuse liver diseases. Thus, a wide range of diffuse liver diseases beside localized hepatic lesions can he evaluated by US. It can also make the diagnosis of portal hypertension 2-4 In our unit, the patient with a suspected hepatobiiary disorder is examined by US on the first day of hospital visit, and the next investigation that will pOssibly provide a definitive diagnosis, such as ERCP, PTC, X-ray CT, angiography, scintigraphy, etc., is scheduled. Using a specially designed transducer, a needle can be guided while the vessel, a duct, or a structure is being aimed and entered (US-guided puncture). 5 ;7 US-guided puncture technique has improved the procedure for percutaneous transhepatic cholangiogrpahy 8, biliary decompression, percutaneous transhepatic catheterizatiøn for portography 9, and obliteration of bleeding varices.
    [Show full text]
  • Icd-9-Cm (2010)
    ICD-9-CM (2010) PROCEDURE CODE LONG DESCRIPTION SHORT DESCRIPTION 0001 Therapeutic ultrasound of vessels of head and neck Ther ult head & neck ves 0002 Therapeutic ultrasound of heart Ther ultrasound of heart 0003 Therapeutic ultrasound of peripheral vascular vessels Ther ult peripheral ves 0009 Other therapeutic ultrasound Other therapeutic ultsnd 0010 Implantation of chemotherapeutic agent Implant chemothera agent 0011 Infusion of drotrecogin alfa (activated) Infus drotrecogin alfa 0012 Administration of inhaled nitric oxide Adm inhal nitric oxide 0013 Injection or infusion of nesiritide Inject/infus nesiritide 0014 Injection or infusion of oxazolidinone class of antibiotics Injection oxazolidinone 0015 High-dose infusion interleukin-2 [IL-2] High-dose infusion IL-2 0016 Pressurized treatment of venous bypass graft [conduit] with pharmaceutical substance Pressurized treat graft 0017 Infusion of vasopressor agent Infusion of vasopressor 0018 Infusion of immunosuppressive antibody therapy Infus immunosup antibody 0019 Disruption of blood brain barrier via infusion [BBBD] BBBD via infusion 0021 Intravascular imaging of extracranial cerebral vessels IVUS extracran cereb ves 0022 Intravascular imaging of intrathoracic vessels IVUS intrathoracic ves 0023 Intravascular imaging of peripheral vessels IVUS peripheral vessels 0024 Intravascular imaging of coronary vessels IVUS coronary vessels 0025 Intravascular imaging of renal vessels IVUS renal vessels 0028 Intravascular imaging, other specified vessel(s) Intravascul imaging NEC 0029 Intravascular
    [Show full text]
  • Colorectal T91-T105 W89 T91
    Gut 1995; 36 (suppl 1) A23 Colorectal T91-T105 W89 T91 LANSOPRAZOLE PROVIDES GREATER SYMPTOM RELIEF THAN COLORECTAL CANCER SCREENING: THE EFFECT OF OMEPRAZOLE IN REFLUX OESOPHAGITIS. A S Mee, J L Rowley COMBINING FLEXIBLE SIGMOIDOSCOPY WITH A FAECAL Gut: first published as 10.1136/gut.36.Suppl_1.A23 on 1 January 1995. Downloaded from and the Lansoprazole Study Group; Royal Berkshire & Battle OCCULT BLOOD TEST. D H Bennett, M R Robinson, P Preece, V Moshakis, Hospitals NHS Trust, Reading, RG1 SAN, UK. K D Vellacott, S Besbeas, J Kewenter, 0 Kronborg, S Moss, J Chamberlain & J D Hardcastle; Lansoprazole, a second generation proton pump inhibitor, provides Department of Surgery, University Hospital, effective symptom relief and healing in reflux oesophagitis. Its greater Nottingham NG7 2UH. bioavailability compared to omeprazole results in superior initial acid suppression. This study was to compare symptom relief and The role of endoscopy in colorectal cancer designed screening is currently under discussion. A healing rates in patients with reflux oesophagitis. prospective, randomised European study is in Methods 604 patients with endoscopically proven reflux progress assessing the benefit of combining oesophagitis, were randomly assigned to receive lansoprazole 30mg or Flexible Sigmoidoscopy (S) with Haemoccult (H) in omeprazole 20mg daily for up to 8 weeks. Daily assessment of screening asymptomatic persons between 50-74 was made the a Visual Scale. years. Subjects were randomised to screening by symptoms by patient using Analogue both S+H (Group 1) or H alone (Group 2). Clinical symptoms were evaluated at weeks 1, 4 and 8. Endoscopic assessment of healing, defined by normalisation of the oesophageal Number Randomised mucosal appearance, was made at weeks 4 and 8.
    [Show full text]